1. Introduction {#sec1}
===============

Rheumatoid arthritis (RA) is an autoimmune systemic illness marked by progressive chronic inflammation of the synovial membrane. It influences many joints, starting from small and then large joints, with involvement of extrarticular tissues and finally comes to an end with pain-affected mortality.^[@ref1]^ Signs and symptoms of RA involve pain, rigidity in ankle joints, progressing immobility, and malformation in the late stage.^[@ref2]^ Internationally, the prevalence of RA is 2--4%; however, probabilities differ among different genders, ethnic and age groups, and geographic clusters,^[@ref3]^ yet the involvement of environmental and genetic aspects is also very much responsible for the development of arthritis.^[@ref4]^

The precise cause of the disease is not known to date; however, a rise in proinflammatory cytokines, chiefly interleukin (IL) 1β, and interleukin-6 and metabolizing enzymes like lipo-oxygenase and cyclooxygenase (COX) and a decrease in anti-inflammatory cytokines, principally IL-10 and IL-4, are indicated.^[@ref5]^ Moreover, nuclear factor (NF)-kB affects numerous cellular tasks involving the immune response of cell proliferation in RA. Nuclear factor-kB is remarkably elevated in arthritis.^[@ref6]^ Free radicals are important factors in the development of disease.^[@ref7]^

Disease-modifying antirheumatic drugs, steroids, other antirheumatic drugs, and nonsteroidal anti-inflammatory medications are used in the treatment of RA. Although these medications give symptomatic comfort, these treatments are harmful for important body parts and lead to stroke and hypertension.^[@ref5]^ Thus, currently, herbal treatment is being adopted to address organ toxicity, drug resistance, and increased cost of these medications.^[@ref8]^ Their therapeutic and pharmacological activities are due to different phytochemical constituents.

*Alternanthera bettzickiana* (local name Nanthara), belonging to the Amaranthaceae family, is a thick and erect perennial herb, which is cultivated in many areas of the world, including Pakistan. It is native to South America and is often known in English as red calico plant, Baptist plant, or border plant. The Amaranthaceae family is composed of only the genus *Alternanthera*, having 80 species.^[@ref9]^ It is commonly used as an ornamental bordering plant. It possesses food and ornamental worth. Leaves are either reddish or green and occasionally both. In Southeast Asia, its shoots and leaves are consumed like spinach or vegetable and in soups, cooked alone, or with other vegetables like amaranth or cowpeas and served with ugali or rice.^[@ref9]^ It grows in moist places near ditches, mesh areas, or open wastelands.^[@ref10]^ It is claimed that the plant has blood-purifying, wound-healing, and fever-alleviating properties, in addition to its galactagogue and soft laxative properties.^[@ref11]^ It has also been used traditionally for alleviating gastrointestinal discomfort and prevention of dementia.^[@ref12]^ It is used in Thailand for treating arthritis.^[@ref13]^*A. bettzickiana* is reported to possess antimicrobial, antioxidant, hemolytic, anti-inflammatory, diuretic, mutagenic, cytotoxic, and anti-Alzheimer's properties.^[@ref11],[@ref14]^

*A. bettzickiana* contains alkaloids, flavonoids, phenolics, tannins, oxalates, glycosides, steroids, saponins, terpenoids, diterpenes, leucoanthocyanin, carbohydrates, coumarins, anthocyanin, xanthoproteins, proteins, carboxylic acid, oil, fats, quinones, and sterol.^[@cit14c],[@cit14d],[@ref15]^ Data showed that fatty acids (linoleic acid) and diterpene alcohol (phytol) are present in *A. bettzickiana*, which have been reported to possess therapeutic indication for treating RA.^[@ref9]^ Hence, due to the traditional use of *A. bettzickiana* and its reported phytoconstituents, it is valuable to assess the antiarthritic potential of *A. bettzickiana*, as no study has been performed to determine its potential in treating RA.^[@ref11]^ The current study aimed at providing scientific insights into the antiarthritic potential of *A. bettzickiana*. First, the plant was characterized, and *in silico* molecular docking was performed next. *A. bettzickiana* was evaluated for its antiarthritic potential using *in vitro* and *in vivo* assays, and real-time polymerase chain reaction (RT-PCR) was performed.

2. Results {#sec2}
==========

2.1. Physicochemical and Phytochemical Analyses {#sec2.1}
-----------------------------------------------

Physicochemical analysis displayed that aerial parts of *A. bettzickiana* have different moisture and ash contents (acid-insoluble ash, water-insoluble ash, total ash, and sulfated ash). Water-insoluble ash (42%) was found higher than acid-insoluble ash (25%) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Alcohol-soluble extractives (5.6%) were higher compared to water-soluble (0.02) extractives. The results of phytochemical analysis showed that ethanolic extract displayed higher phenolic contents (7.607 ± 1.15 mg/g) than alkaloid contents (2.26 ± 0.28 mg/g) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)). The extract displayed the highest flavonoid contents (70.66 ± 4.61 mg/g).

###### Physicochemical and Phytochemical Analyses of *A. bettzickiana*

  sr no   physicochemical parameter     \% age   phytochemical parameters   quantity (mg/g)
  ------- ----------------------------- -------- -------------------------- -----------------
  1       moisture contents             5        total alkaloids            2.26 ± 0.28
  2       total ash contents            20                                  
  3       water-insoluble ash           42       total phenolics            7.607 ± 1.15
  4       acid-insoluble ash            25                                  
  5       sulfated ash                  67       total flavonoids           70.66 ± 4.61
  6       water-soluble extractives     0.02                                
  7       alcohol-soluble extractives   5.6                                 

2.2. High-Performance Liquid Chromatographic (HPLC) Analysis {#sec2.2}
------------------------------------------------------------

HPLC analysis of *A. bettzickiana* was performed for the determination of compounds present in ethanolic extract of *A. bettzickiana* aerial parts. Peaks of all compounds were then compared with the standard. [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} illustrates the identified compounds with quantity, area, and retention time. The HPLC examination of ethanolic extract of *A. bettzickiana* identified catechin (864.714 ppm), gallic acid (436.69 ppm), sinapic acid (104.11 ppm), chlorogenic acid (CA) (37.88 ppm), α-tocopherol (25.06 ppm), quercetin (QTN) (3.5881 ppm), and γ-tocopherol (0.11946 ppm). Catechin and gallic acid were present in higher quantities as compared to other compounds ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} and [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![HPLC chromatograms of *A. bettzickiana* ethanolic extract and standards. (a) Phenolics in sample, (b) standard phenolics, (c) vitamins in sample, and (d) standard vitamin.](ao0c01670_0001){#fig1}

###### HPLC Analysis of *A. bettzickiana* Ethanolic Extract (ABEE) and Standard Drug Diclofenac Sodium

  peak no   compound           retention time (min)   area           height       concentration (ppm)
  --------- ------------------ ---------------------- -------------- ------------ ---------------------
  1         gallic acid        2.697                  5 527 770.80   516 201.80   436.69
  4         catechin           3.355                  2 305 904.40   247 320.30   864.714
  5         chlorogenic acid   5.35                   199 420.10     15 055.40    37.889
  9         sinapic acid       12.106                 2 082 207.00   191 300.00   104.11
  11        quercetin          24.867                 37 770.50      3880.60      3.5881
  15        γ-tocopherol       11.814                 2596           256.2        0.11946
  17        α-tocopherol       13.178                 1 044 336.90   79 893.4     25.06

  standards                                               
  ----------- ------------------- -------- -------------- ------------
  1           gallic acid         2.806    544 037.40     71 328.60
  4           catechin            3.386    338 226.60     49 771.50
  5           chlorogenic acid    5.227    104 856.70     11 091.50
  6           *p*-coumeric acid   5.596    116 404.20     12 438.00
  7           BHT                 7.041    762 383.80     80 103.70
  8           caffeic acid        7.842    1 318 761.30   70 615.50
  9           sinapic acid        12.679   344 898.50     33 079.70
  10          ferulic acid        12.967   542 153.20     51 932.40
  11          quercitin           24.893   270 762.40     20 610.20
  17          γ-tocopherol        11.914   996 724.60     85 238.00
  18          α-tocopherol        13.313   1 788 882.60   137 386.30

2.3. *In Silico* Molecular Docking {#sec2.3}
----------------------------------

The phytochemicals were *in silico* docked onto cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) to investigate their anti-inflammatory potential in arthritis. The cognate redocking validated the docking protocols for COX-1 and COX-2 with 0.8085 and 0.7127 of root-mean-square deviation (RMSD) to cocrystallized ligands, respectively ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)).

The induced fit docking highlighted that ibuprofen inhibits COX-1 and COX-2 with −6.51 and −6.57 kcal/mol Δ*G*, respectively, thus being established as the standard threshold ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)). Interestingly, γ-tocopherol significantly exceeded the COX-1 standard threshold with −8.15 kcal/mol Δ*G* and has been highlighted as the most potent inhibitor of COX-1. α-Tocopherol binds to COX-1 with −8.04 kcal/mol binding energy and exhibited comparable binding affinity to γ-tocopherol and significantly exceeded the standard threshold to inhibit COX-1. These compounds were followed by the binding affinity of sinapic acid with −6.65 kcal/mol Δ*G*, which exceeded the standard's threshold but comparably inhibited COX-1 to ibuprofen. On the other hand, α-tocopherol appeared as the most potent inhibitor of COX-2, which exceeded its standard threshold by −8.98 kcal/mol binding energy. The binding affinity of α-tocopherol was followed by catechin and quercetin, which exceeded the COX-2 standard threshold by −7.87 and −7.65 kcal/mol Δ*G*, respectively, and has been highlighted as potential selective inhibitors of COX-2.

The spatial analysis revealed that ibuprofen penetrated the cyclooxygenase pocket and disrupted the H-bond network of polar residues of the constriction site of the active site to establish its conformation ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)). Furthermore, it was found to penetrate into the broader hydrophobic channel of the globular catalytic site and established contacts with the roof of the cyclooxygenase channel. Similarly, γ-tocopherol also disrupted the polar network of the constriction site and penetrated into the hydrophobic channel of the cyclooxygenase pocket to block its globular catalytic site and then extended toward the roof of the pocket and blocked the solvent channel of the active site, thereby inhibiting COX-1 by diverse inhibitory mechanisms.^[@ref16]^ On the other hand, α-tocopherol binds to the peripheral site of the active site and may hinder the entry of the COX-1 substrate. However, sinapic acid efficiently penetrated into the binding pocket and established its conformation within the hydrophobic and solvent cavity of the cyclooxygenase pocket.

COX-2 shares a similar sequence identity to COX-1 and exhibits the conserved structural features of COX-1. However, the exchange of residues causes the modification of the secondary structure and mediates the passage to the restricted hydrophilic side pocket, interaction with which determines the COX-2 selectivity.^[@ref17]^ The conformational analysis revealed that all of the ligands bind to the same pocket, stabilized their conformation at the hydrophobic channel of the cyclooxygenase pocket, and flipped toward the restricted hydrophilic side pocket, thus highlighting their potential to selectively inhibit COX-2 ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)).

The ibuprofen complexed with COX-1 by H-bonding with ARG120 and TYR355 at the constriction site and penetrated into the large hydrophobic channel and roof of the cyclooxygenase pocket by establishing hydrophobic interactions with ALA527, VAL349, LEU359, LEU352, TYR385, TRP387, and PHE518 ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)). γ-Tocopherol disrupted the H-bond networks of ARG120 and TYR355 *via* π-cation and alkyl interactions at the constriction site, respectively. Furthermore, it flipped toward the cyclooxygenase pocket by establishing hydrophobic interactions with ILE523, ILE89, PHE518, VAL116, VAL119, PRO86, and LEU531 of the hydrophobic globular catalytic pocket. It further extended into the roof of the cyclooxygenase pocket by hydrophobic interactions with TRP387, LEU352, TYR385, and LEU384 and blocked the solvent cavity of the active site, thus emerging as a potent inhibitor of COX-1. The conformation of α-tocopherol was mainly established by hydrophobic interactions with PRO84, ILE89, VAL116, LEU115, LEU123, TRP100, LEU112, and PRO86 at the entry of the binding pocket and inhibited substrate access. Sinapic acid was found to complex with the hydrophobic channel and flipped to the roof of the cyclooxygenase pocket by hydrophobic interactions with ALA527 and VAL349, where it was also found to establish H-bonds with SER353, thus blocking the solvent cavity from disrupting substrate accommodation within the active site.

Ibuprofen complexation was stabilized by hydrophobic interactions with hydrophobic channels of LEU517, ALA513, GLY512, and PHE504 in the COX-2 active site. It also extended to the roof of the cyclooxygenase channel by hydrophobic interactions with LEU345, TYR341, TRP373, LEU338, and VAL335 to inhibit COX-2 ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)). α-Tocopherol complexed mainly by hydrophobic interactions with ARG499, VAL509, and ALA502 at the hydrophilic side pocket, which exhibited selectivity toward COX-2 inhibition. Moreover, it also extended toward the roof of the cyclooxygenase pocket by establishing hydrophobic interactions with TRP373, TYR371, Val335, LEU338, and TYR341 to inhibit the catalytic activity of COX-2. Catechin was found to establish hydrophobic interaction with VAL509, SER339, and LEU338 and H-bonds with HIS75, GLN178, and TYR341, thus selectively inhibiting the COX-2 hydrophilic pocket along with its globular catalytic domain. Quercetin established a H-bond with MET508 and hydrophobic interaction with ALA513 and VAL509 at the hydrophilic domain to selectively inhibit COX-2. In addition, it also complexed with hydrophobic and H-bond interactions with LEU338 and TYR341 at the hydrophobic channel to further inhibit the cyclooxygenase cavity of COX-2. Therefore, these studies provide plausible insights into the superior inhibitory mechanism of phytochemicals to comprehensively and selectively block the cyclooxygenase activity.

2.4. Antioxidant Activity {#sec2.4}
-------------------------

Results showed the antioxidant potential of *A. bettzickiana* in all models. The IC~50~ values of the ethanolic extract of *A. bettzickiana* in 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 2,2-diphenyl-1-picryl hydrazyl (DPPH) assays were 103.87 ± 5.77 and 135.07 ± 21.36, respectively, while those of ascorbic acids were 18.50 ± 2.88 and 11.37 ± 1.732, respectively. The ferric reducing potential of the extract in the ferric reducing antioxidant power (FRAP) assay was 455.24 ± 26.55. The extract showed dose-dependent free radical scavenging and reducing potential in these assays ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf)).

2.5. Assessment of the Antiarthritic Potential: *In Vitro* Assays {#sec2.5}
-----------------------------------------------------------------

ABEE displayed significant (*p* \< 0.001) inhibition of denaturation of egg albumin dose-dependently. ABEE exhibited 94.23% inhibition at 6400 μg/mL concentration and was found to be immensely efficacious in comparison to the standard drug diclofenac sodium (72.27%) at 6400 μg/mL. Similarly, ABEE and the standard drug diclofenac sodium significantly (*p* \< 0.001) inhibited BSA from denaturation. At 6400 μg/mL, ABEE and the standard displayed 97.43 ± 0.70 and 75.43 ± 0.70 protection of BSA from heat denaturation, respectively. Results were more eminent than the standard drug ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### *In Vitro* Antiarthritic Activity of *A. bettzickiana* Ethanolic Extract[a](#t3fn1){ref-type="table-fn"}^,^[b](#t3fn2){ref-type="table-fn"}

                  concentration (μg/mL)                                                                                                                                                                               
  --------------- --------------------------------------------------------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- ----------------
                  Egg Albumin Denaturation Inhibition                                                                                                                                                                 
  standard drug   72.27 ± 1.00                                                          70.14 ± 2.30         64.03 ± 2.47         61.03 ± 1.58         60.57 ± 2.23         49.54 ± 3.80         44.23 ±1.00          36.93 ± 1.58
  ABEE            94.23 ± 2.72\*\*\*                                                    90.79 ± 2.37\*\*\*   89.91 ± 1.14\*\*\*   83.54 ± 2.72\*\*\*   79.03 ± 3.58\*\*\*   64.54 ± 2.98\*\*\*   55.23 ± 0.70\*       46.93 ± 2.02\*
                  Inhibition of Protein Denaturation Using Bovine Serum Albumin (BSA)                                                                                                                                 
  standard drug   75.43 ± 0.70                                                          71.93 ± 1.58         68.91 ± 2.72         66.34 ± 1.14         55.32 ± 2.47         42.45 ± 1.00         35.49 ±1.98          33.71 ± 3.60
  ABEE            97.43 ± 0.70\*\*\*                                                    92.73 ± 1.74\*\*\*   90.91± 2.47\*\*\*    88.34 ± 3.36\*\*\*   73.32 ± 2.86\*\*\*   60.45 ± 1.14\*\*\*   49.29 ± 1.58\*\*\*   43.71 ± 2.02\*

Results are presented as mean ± standard error of the mean (SEM) (*n* = 5) and analyzed by two-way analysis of variance (ANOVA), followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001 and \**p* \< 0.05 as compared to disease control.

ABEE, *A. bettzickiana* ethanolic extract.

2.6. *In Vivo* Assessment of the Antiarthritic Potential of ABEE against Complete Freund's Adjuvant (CFA)-Induced Arthritis {#sec2.6}
---------------------------------------------------------------------------------------------------------------------------

### 2.6.1. Effects on Paw Diameter {#sec2.6.1}

Subplantar injection of the adjuvant increased the swelling, producing maximum inflammation recorded on the 7th day. A significant increase in paw diameter in control animals was noticed during days 8--28, in contrast to the vehicle control animals. Treatment with ABEE reduced the paw thickness as compared to disease control rats, with the highest effectiveness noticed at 1000 mg/kg concentration ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Percentage inhibition shown by ABEE at 1000 mg/kg (70.56%) and 500 mg/kg (65.81%) was significantly (*p* \< 0.001) greater than standard-drug-treated animals (55.65%) on the 28th day ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The best dose of ABEE, which exhibited the maximum reduction in paw diameter, was 1000 mg/kg.

![Effects of ethanolic extract of *A. bettzickiana* on paw diameter against CFA-induced arthritis before sacrificing on days 0, 3, 7, 14, 21, and 28. (A) Disease control; (B) standard drug diclofenac sodium treated; (C, E, F) treatment with 250, 500, and 1000 mg/kg extract, respectively; (D) days (figures were captured and compiled by Maria Manan).](ao0c01670_0002){#fig2}

###### Effects of *A. bettzickiana* Ethanolic Extract on Paw Diameter of CFA-Induced Arthritic Rats[a](#t4fn1){ref-type="table-fn"}

                             paw diameter                                                                                                                                
  -------------------------- ------------------------- ------------------------- -------------------------- ------------------------------ ----------------------------- ----------------------------
  vehicle control            2.90 ± 0.06^ns^           2.88 ± 0.07\*\*\*         2.87 ± 0.07\*\*\*          2.81 ± 0.07\*\*\*              2.88 ± 0.07\*\*\*             2.86 ± 0.07\*\*\*
  disease control            2.73 ± 0.07               8.5 ± 0.13                10.8 ± 0.30                13.5 ± 0.36                    18.4 ± 0.38                   21.06 ± 0.94
  standard drug (10 mg/kg)   2.55 ± 0.66^ns^ (6.59%)   7.52 ± 0.45^ns^ (11.5%)   10.58 ± 0.38^ns^ (2.03%)   10.28 ± 0.38\*\*\* (23.33%)    9.52 ± 0.47\*\*\* (48.26%)    8.62 ± 0.38\*\*\* (59.06%)
  ABEE (250 mg/kg)           2.26 ± 0.05^ns^ (7.2%)    8.40 ±0.31^ns^ (0.11%)    10.68 ± 0.39^ns^ (1.11%)   10.42 ± 0.381\*\*\* (22.81%)   10.18 ± 0.38\*\*\* (44.67%)   9.34 ± 0.46\*\*\* (55.65%)
  ABEE (500 mg/kg)           2.63 ± 0.04^ns^ (3.66%)   8.30 ± 0.31^ns^ (2.35%)   10.50 ± 0.38^ns^ (2.77%)   10.34 ± 0.35\*\*\* (23.40%)    9.60 ± 0.45\*\*\* (47.82%)    7.2 ± 0.34\*\*\* (65.81%)
  ABEE (1000 mg/kg)          2.54 ± 0.07^ns^ (6.95%)   8.20 ± 0.31^ns^ (3.52%)   10.24 ± 0.35^ns^ (5.18%)   9.82 ± 0.36\*\*\* (27.25%)     8.10 ± 0.31\*\*\* (55.92%)    6.20 ± 0.42\*\*\* (70.56%)

Results are presented as mean ± SEM (*n* = 5) and analyzed by two-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001 as compared to the disease control. ABEE, *A. bettzickiana* ethanolic extract.

### 2.6.2. Effect on Arthritic Index {#sec2.6.2}

Vehicle control animals did not exhibit any inflammation throughout the study. The outcomes presented in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} exhibited a continuing increase in the arthritic score expressed by disease control animals. Treatment with ABEE and the standard drug significantly (*p* \< 0.001) reduced the arthritic score in contrast to disease control rats on days 14--28. The highest arthritic score was observed at the end of study in disease control rats (6.40 ± 0.245), which was reinstated by ABEE at 1000 mg/kg (2.20 ± 0.20), 500 mg/kg (2.40 ± 0.245), and 250 mg/kg (2.80 ± 0.20) and standard drug (2.40 ± 0.245) treatments.

![Effects of ethanolic extract of *A. bettzickiana* on arthritic scoring against CFA induced arthritis. Results are presented as mean ± SEM (*n* = 5) and analyzed by two-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001 and \**p* \< 0.05 compared to the disease control.](ao0c01670_0003){#fig3}

### 2.6.3. Effect on Body Weight {#sec2.6.3}

There was a continual decrease in weight as swelling continued. Outcomes exhibited in [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf) showed that weight reduction was eminent in disease control rats in contrast to the vehicle control group during days 7--28. Contrarily, treatment with ABEE and the standard drug diclofenac sodium significantly (*p* \< 0.001) reinstated body weight in comparison with disease control rats from the 7th day to the end of study. ABEE at 1000 mg/kg dose most effectively increased the body weight of arthritic rats.

### 2.6.4. Effect on Hematological and Biochemical Variables {#sec2.6.4}

It was observed that injection of CFA caused elevated levels of aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine aminotransferase (ALT), C reactive protein (CRP), and rheumatoid factor (RF). Administration of ABEE and the standard drug diclofenac sodium resulted in significant reductions in CRP, AST, ALP, ALT, and RF (*p* \< 0.001) levels. Biomarker levels like RF and CRP were elevated (33.4 ± 3.16 and 25.31 ± 1.70, respectively) in disease control rats ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). However, ABEE decreased RF and CRP in animals administered with ABEE at 1000 mg/kg (15.5 ± 1.41 and 12.5 ± 1.14, respectively) in comparison with standard drug diclofenac sodium treatment (13.4 ± 1.14 and 13.4 ± 1.00, respectively).

###### Effects of Ethanolic Extract of *A. bettzickiana* on Hematological and Biochemical Variables in CFA-Induced Arthritic Rats[a](#t5fn1){ref-type="table-fn"}

  parameters             vehicle control       disease control   standard (10 mg/kg)   ABEE (250 mg/kg)       ABEE (500 mg/kg)     ABEE (1000 mg/kg)
  ---------------------- --------------------- ----------------- --------------------- ---------------------- -------------------- ---------------------
  Hb (g/dL)              27.20 ± 3.11\*\*\*    10.1 ± 2.98       23.0 ± 3.18\*\*\*     11.9 ± 2.02^ns^        14.0 ± 1.58\*\*      22 ± 1.14\*\*\*
  ESR (mm/1st hour)      7 ± 2.02\*\*\*        25 ± 1.84         14 ± 2.02\*\*\*       24 ± 1.58^ns^          21 ± 2.12\*\*        9 ± 1.41\*\*\*
  RBCs (×10^12^/L)       17.9 ± 1.58\*\*\*     6.2 ± 1.58        13 ± 1.14\*\*\*       8.2 ± 1.00^ns^         10.0 ± 1.84\*\*\*    17.2 ± 1.14\*\*\*
  WBCs (×10^9^/L)        8.3 ± 1.14\*\*\*      24 ± 1.30         8.9 ± 0.11\*\*\*      21.3 ± 1.14^ns^        19.8 ± 1.14\*\*\*    9.2 ± 0.70\*\*\*
  platelets (×10^9^/L)   596 ± 2.12\*\*\*      1029 ± 12.72      624 ± 7.21\*\*\*      864 ± 2.91\*\*\*       813 ± 15.84\*\*\*    613 ± 9.38\*\*\*
  AST (U/L)              110.90 ± 0.44\*\*\*   159.74 ± 0.47     127.20 ± 0.44\*\*\*   156.4 ± 1.00\*\*       154.7 ± 1.78\*\*\*   121.8 ± 0.44\*\*\*
  ALP (U/L)              180.40 ± 8.68\*\*\*   390.30 ± 5.63     195.6 ± 2.40\*\*\*    322.10 ± 16.64\*\*\*   305.3 ± 9.30\*\*\*   198.40 ± 9.51\*\*\*
  ALT (U/L)              19 ± 2.12\*\*\*       47 ± 2.40         36 ± 0.70\*\*\*       46 ± 1.14^ns^          43 ± 1.14\*          36 ± 0.70\*\*\*
  urea (mg/dL)           12.5 ± 2.0\*\*\*      39.4 ± 1.58       19.18 ± 2.29\*\*\*    35 ± 0.70\*\*\*        31.2 ± 0.63\*\*\*    19.2 ± 0.70\*\*\*
  creatinine (mg/dL)     1.30 ± 0.29\*\*\*     5.9 ± 0.79        1.28 ± 0.16\*\*\*     4.9 ± 0.82^ns^         2.2 ± 0.14\*\*       1.20 ± 0.20\*\*\*
  CRP (mg/L)             12.2 ± 2.0\*\*\*      25.31 ± 1.70      13.4 ± 1.00\*\*\*     22.5 ± 1.41\*          19.6 ± 2.20\*\*\*    12.5 ± 1.14\*\*\*
  RF (IU/mL)             12.5 ± 2.12\*\*\*     33.4 ± 3.16       13.4 ± 1.14\*\*\*     32.3 ± 2.72^ns^        30.6 ± 1.84\*\*      15.5 ± 1.41\*\*\*
  BUN (mg/dL)            13.5 ± 1.41\*\*\*     34.2 ± 1.58       15.6 ± 0.70\*\*\*     31.4 ± 2.91\*          29.6 ± 1.14\*\*\*    16.2 ± 1.58\*\*\*

Results are presented as mean ± SEM (*n* = 5) and analyzed by two-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001, \*\**p* \< 0.01, and \**p* \< 0.05 as compared to the disease control. Here, Hb, hemoglobin; ESR, erythrocyte sedimentation rate; RBCs, red blood cells; WBCs, white blood cells; AST, aspartate aminotransferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; CRP, C reactive protein; RF, rheumatoid factor; BUN, blood urea nitrogen; HDL, high-density lipoprotein; LDL, low-density lipoprotein. ABEE, *A. bettzickiana* ethanolic extract.

Urea, creatinine, and BUN significantly increased (39.4 ± 1.58, 5.9 ± 0.79, and 34.2 ± 1.58, respectively) in disease control rats. However, ABEE significantly decreased urea, creatinine, and BUN levels in animals administered with ABEE at 1000 mg/kg (19.2 ± 0.70, 1.20 ± 0.20, and 16.2 ± 1.58, respectively), while the standard drug diclofenac sodium also significantly decreased urea, creatinine, and BUN levels (19.18 ± 2.29, 1.28 ± 0.16, and 15.6 ± 0.70, respectively). RBCs and Hb levels were reduced, while WBCs, ESR, and platelets were found to be increased in disease control animals in comparison with vehicle control rats. Concentration-dependent ameliorating action of ABEE on aforementioned hematological variables was noticed. The best dose of ABEE that exhibited maximum inhibition in abnormal alterations in hematological and biochemical variables was 1000 mg/kg ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}).

### 2.6.5. Effect on Histopathology {#sec2.6.5}

The outcomes of joint histopathology after completion of study exhibited remarkable pannus formation and synovial hyperplasia. Infiltration of inflammatory cells, cartilage destruction, and bone erosion in disease control animals were observed in comparison to vehicle control animals. Treatment with ABEE decreased pannus formation, synovial hyperplasia, infiltration of inflammatory cells, and bone erosion at all concentrations in contrast with disease control rats, as shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. The effect of ABEE on bone erosion, pannus formation, and paw swelling was comparable to that of the standard drug diclofenac sodium. Gross macroscopic investigation of the hind paw before slaughter is shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. It was evident that there was pronounced swelling in disease control animals, while treated animals showed minimal (1000 mg/kg), light (500 mg/kg), and average (250 mg/kg) swelling on day 28.

![Effects of *A. bettzickiana* ethanolic extract on histopathological analysis of ankle joints in arthritic rats injected by complete Freund's adjuvant at 40× and 20× magnification. (A) Vehicle control; (B) disease control; (C) rats treated with the standard drug diclofenac sodium; (D--F) paw histology of rats administered with ethanolic extract at 250, 500, and 1000 mg/kg, respectively.](ao0c01670_0004){#fig4}

### 2.6.6. Effect on Radiographic Findings {#sec2.6.6}

Radiographic investigation exhibited rigorous soft tissue inflammation, intensive bone erosion, marked joint space narrowing, extensive and thickened connective tissue, immense joint deformity, and joint resorption in the joints of disease control animals in contrast to vehicle control animals, which exhibited no bone erosion, usual joint gaps, no soft tissue inflammation, normal connective tissue, and no bone erosion. Standard-drug-administered animals showed bone resorption and erosion, soft tissue inflammation, definite joint gap reduction, and considerable connective tissue expansion. Similarly, radiographic alterations were ameliorated in all *A. bettzickiana*-administered animals when compared with disease control rats, as shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. Rats administered with 1000 mg/kg ABEE showed distinct extension of connective tissues, mild bone erosion and resorption, joint deformity, slight soft tissue inflammation, and obvious joint gap reduction. However, rats administered with 500 mg/kg ABEE showed moderate soft tissue inflammation and alterations of joint spaces, notable bone erosion, modest joint deformity, and noticeably thickened connective tissues. ABEE at 250 mg/kg revealed visibly soft tissue inflammation, notable joint gap diminution and deformity, pronounced expansion of connective tissue, and reduced bone mass. The best dose of ABEE that exhibited maximum amelioration in radiographic changes was 1000 mg/kg.

![Radiographic assessment of limbs of CFA-induced rats treated with ethanolic extract of *A. bettzickiana*. (A) Vehicle control; (B) disease control; (C) rats treated with the standard drug diclofenac sodium; (D--F) rats treated with ethanolic extract at 250, 500, and 1000 mg/kg, respectively.](ao0c01670_0005){#fig5}

2.7. Determination of the mRNA Expression Level by RT-PCR {#sec2.7}
---------------------------------------------------------

The mRNA expressions of different proinflammatory and anti-inflammatory biomarkers in blood samples were analyzed after completion of study in rats. The results are discussed next.

### 2.7.1. Proinflammatory Biomarkers {#sec2.7.1}

The mRNA NF-kB expression was significantly raised (*p* \< 0.001) in the disease control group (5.08 ± 1.15-fold) as compared to the vehicle control group. However, this increase in NF-kB expression was alleviated in different treatment groups. Decrease in NF-kB expression was observed with ABEE at 1000 mg/kg (1.53 ± 0.11-fold), 500 mg/kg (2.18 ± 0.09-fold), and 250 mg/kg (4.36 ± 0.63-fold) and diclofenac sodium (1.44 ± 0.068-fold) in treated rats ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a). The maximum effect was noted with 1000 mg/kg dose of extract in contrast to 500, 250 mg/kg, and the standard drug diclofenac sodium.

![Effect of *A. bettzickiana* ethanolic extract on mRNA expression: (a) NF-kB, (b) COX-2, (c) IL-6, (d) tumour necrosis factor (TNF)-α, (e) IL-1β, (f) IL-4, (g) IL-10, and (h) I-kB. Results are presented as mean ± SEM (*n* = 5) and analyzed by one-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001, \*\**p* \< 0.01, and \**p* \< 0.05 as compared to the disease control. ABEE, *A. bettzickiana* ethanolic extract.](ao0c01670_0006){#fig6}

An increased COX-2 expression (*p* \< 0.001) was noticed in disease control rats (7.21 ± 0.64-fold) in contrast to vehicle control animals. This increase in COX-2 expression was decreased in various treatment groups. Treatment with ABEE at 1000 mg/kg (3.40 ± 0.60-fold), 500 mg/kg (4.1 ± 0.81-fold), and 250 mg/kg (5.70 ± 0.88-fold) and diclofenac sodium (3.50 ± 0.68-fold) administration significantly decreased COX-2 expression in treatment groups ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}b). The highest decrease in COX-2 expression was observed with 1000 mg/kg extract.

Similarly, the significantly elevated (*p* \< 0.001) expression of IL-6 in the disease control group (7.68 ± 0.08-fold) was notably reduced with ABEE at 1000, 500, and 250 mg/kg and diclofenac sodium (2.78 ± 0.57-fold, 4.90 ± 0.04-fold, 5.10 ± 0.74-fold, and 4.90 ± 0.51-fold, respectively) treatments in rats ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}c). These results demonstrated that ABEE at 1000 mg/kg proved to be the most effective in comparison with 500, 250 mg/kg, and standard drug diclofenac sodium.

Similarly, the expression of TNF-α ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}d) was significantly upregulated (*p* \< 0.001) in blood of disease control animals (6.35 ± 0.17-fold) in contrast to vehicle control rats. However, this increase in TNF-α expression was decreased in several treatment groups. Significant reduction in TNF-α expression was noted with ABEE at 1000 mg/kg (2.98 ± 0.20-fold), 500 mg/kg (5.40 ± 0.11-fold), and 250 mg/kg (5.80 ± 0.21-fold) and diclofenac sodium (5.30 ± 0.20-fold) in treatment rats. Maximal alleviation in COX-2 expression was noted with 1000 mg/kg extract.

The mRNA IL-1β expression was considerably increased (*p* \< 0.001) in the untreated control group (5.98 ± 0.73-fold) as compared to the vehicle control group, although this elevation was alleviated by administration of the extract. Treatment with ABEE at 1000, 500, and 250 mg/kg and diclofenac sodium presented notable declines, *i.e*., 1.94 ± 0.20-fold, 4.06 ± 0.07-fold, 4.96 ± 0.1-fold, and 4.10 ± 0.22-fold, respectively ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}e), in the IL-1β expression. These results demonstrated that ABEE at 1000 mg/kg was found to be the most effective in comparison with ABEE at 500 and 250 mg/kg and the standard drug diclofenac sodium.

### 2.7.2. Anti-Inflammatory Biomarkers {#sec2.7.2}

A considerable reduction (*p* \< 0.001) in IL-4 expression was observed in disease control rats (38.36 ± 4.11%) as compared to vehicle control rats. This downregulation of IL-4 expression was elevated in various treatment groups. Elevation in IL-4 expression was observed with ABEE at 1000 mg/kg (80.13 ± 3.53%), 500 mg/kg (68.12 ± 1.41%), and 250 mg/kg (65.23 ± 1.84%) and diclofenac sodium (75.10 ± 8.68%) therapy in treatment rats as compared to disease control rats, as depicted in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}f. Maximum effect was noted with 1000 mg/kg dose of extract in contrast to 500 and 250 mg/kg doses and the standard drug diclofenac sodium.

A significant alleviation (*p* \< 0.001) in IL-10 expression was observed in disease control rats (31.67 ± 2.0%) in comparison with vehicle control rats. However, IL-10 expression was upregulated with ABEE at 1000 mg/kg (78.59 ± 1.70%), 500 mg/kg (67.60 ± 1.28%), and 250 mg/kg (44.98 ± 5.0%) and diclofenac sodium therapy (65.83 ± 5.80%) in treatment rats as compared to disease control rats ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}g). These outcomes demonstrated that ABEE at 1000 mg/kg was found to be the most effective in comparison with ABEE at 500 and 250 mg/kg and the standard drug diclofenac sodium.

A considerable decrease (*p* \< 0.001) in the I-kB expression level was noticed in disease control rats (43.71 ± 2.85%) in contrast to vehicle control rats. This decreased expression in I-kB was elevated in different treatment groups. Upregulation in IL-10 expression was observed by administering ABEE at 1000 mg/kg (81.53 ± 8.20%), 500 mg/kg (71.23 ± 4.66%), and 250 mg/kg (68.21 ± 2.30%) and diclofenac sodium (79.79 ± 3.60%), as depicted in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}h. The highest elevation in I-kB expression was observed with 1000 mg/kg extract.

2.8. Effect on Serum Levels of TNF-α and IL-6: ELISA Study {#sec2.8}
----------------------------------------------------------

An increased concentration of TNF-α (*p* \< 0.001) was observed in the serum of disease control rats (523.38 ± 15.55 pg/mL). However, the increase in TNF-α was significantly reduced by treatment with ABEE at 1000 mg/kg (234.35 ± 21.36 pg/mL) and 500 mg/kg (450.11 ± 0.70 pg/mL) and diclofenac sodium (278.81 ± 11.90 pg/mL) in contrast to the disease control group ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}a). An abnormally elevated concentration of IL-6 was noticed in disease control rats (721.23 ± 23.21 pg/mL). This increased concentration was significantly (*p* \< 0.001) mitigated by ABEE at 1000 mg/kg (347.46 ± 18.20 pg/mL) and 500 mg/kg (427.76 ± 12.28 pg/mL) and diclofenac sodium (378.41 ± 22.66 pg/mL) ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}b). The most effective dose of ABEE, which showed maximum reduction in serum levels of TNF-α and IL-6, was 1000 mg/kg.

![Effect of *A. bettzickiana* ethanolic extract on inflammatory mediators: (a) TNF-α and (b) IL-6. Results are presented as mean ± SEM (*n* = 5) and analyzed by one-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001 and \*\**p* \< 0.01 as compared to the disease control. ABEE, *A. bettzickiana* ethanolic extract.](ao0c01670_0007){#fig7}

2.9. Effect on Oxidative Stress Biomarkers {#sec2.9}
------------------------------------------

The results of oxidative stress and alleviation of ABEE are shown in [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}. Superoxide dismutase (SOD) (4.36 ± 0.707 U/mL) and catalase (CAT) (62.01 ± 7.44 U/L) values were significantly decreased (*p* \< 0.001) in disease control rats as compared to the vehicle control group (SOD: 13.10 ± 1.84 U/mL and CAT: 115.52 ± 1.98 U/L). However, diclofenac sodium (10 mg/kg) and 500 and 1000 mg/kg doses of ABEE restored (*p* \< 0.001) the values of SOD and CAT in the disease control group, as depicted in [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}a,b, respectively. Malondialdehyde (MDA) (1974.40 ± 15.23 ng/mL) and NO (242.33 ± 4.83 μmol/L) levels were also significantly increased (*p* \< 0.001) in the disease control group in comparison to vehicle control rats (MDA: 823.02 ± 9.74 ng/mL and NO: 118.37 ± 15.98 μmol/L). The MDA level was significantly decreased by diclofenac sodium and ABEE in arthritic animals, as depicted in [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}c,d, respectively.

![Effect of *A. bettzickiana* on oxidative stress biomarkers: (a) SOD, superoxide dismutase; (b) catalase; (c) MDA, malondialdehyde; and (d) NO, nitric oxide. Results are presented as mean ± SEM (*n* = 5) and analyzed by one-way ANOVA followed by Bonferroni's post-test. ns, nonsignificant; \*\*\**p* \< 0.001, \*\**p* \< 0.01, and \**p* \< 0.05; ns, nonsignificant as compared to the disease control. ABEE, *A. bettzickiana* ethanolic extract. Results are presented as mean ± SEM (*n* = 5) and analyzed by two-way ANOVA followed by Bonferroni's post-test.](ao0c01670_0008){#fig8}

3. Discussion {#sec3}
=============

Rheumatoid arthritis is marked by a sequence of pathological processes in joints like pannus formation, immense damage of cartilage and bone, and leukocyte infiltration. Traditional therapies have ameliorated this condition with respect to effectiveness. Disease-modifying antirheumatic drugs like suphasalazine, hydroxyl chloroquine, leflunomide, and methotrexate; nonsteroidal anti-inflammatory drugs like etoricoxib; and corticosteroids such as methyl prednisolone and prednisolone have been linked with side effects.^[@ref18]^ Herbal remedies are being utilized increasingly by the public in eastern and western countries due to their compatibility and acceptability, along with having few adverse effects.^[@ref19]^ Revival of herbal remedies for the management of rheumatoid arthritis is well documented.^[@ref18]^

The purpose of physicochemical (ash value, moisture contents, and total extractives) and phytochemical (total phenolics, total flavonoids, total alkaloids) analyses was to standardize the medicinal plant. Stability of the plant material considerably depends on moisture contents. Less moisture content is required for inhibition of microbial contamination and chemical decomposition in medicinal plants.^[@ref20]^ Purity and quality of powdered drugs were assessed by determining the ash value. All organic matter was removed by the ash test. On incineration, drugs leave ash comprising silicates, carbonates, and phosphates of potassium, sodium, calcium, and magnesium. The acid-insoluble ash test determines that the drug has calcium oxalate or silica. Fusibility of sulfated ash is less as compared to normal ash. Hence, sulfuric acid is added to the crude drug before carrying out the ash test.^[@ref21]^ The total ash content determines the level of caution needed for its preparation.

Flavonoid functions include shielding against inflammation, platelet aggregation, allergies, free radicals, hepatotoxins, microbes, tumors, ulcers, and viruses.^[@ref22]^ The presence of polyphenolics in plants shows that *A. bettzickiana* can act as antimicrobial, antioxidant, and hormone modulators and as anti-inflammatory agents. Alkaloids are utilized as analgesics and as bactericidal and anti-inflammatory agents.^[@ref23]^ Physicochemical and phytochemical analyses of medicinal plants are important in recognizing the herb. Petrus et al.^[@ref24]^ have reported that the quantity of polyphenolics found in 100 g of *A. bettzickiana* leaves was 308.526 mg of GAE. This quantity is more than the amount that has been recorded from indigenous leafy vegetables. Total polyphenolics was determined by the spectrophotometric method.^[@ref24]^ Our findings of the total phenolic estimation corroborate with those of Vidhya et al., who reported that the methanolic extract of *A. bettzickiana* exhibited the highest amount of polyphenolics (63 mg of GAE/g of extract) and total flavonoid contents (38.98 mg of QE/g of extract) as compared to the aqueous extract.^[@cit14d]^

The existence of polyphenolics was validated by HPLC. HPLC analysis of the ethanolic extract of *A. bettzickiana* exhibited the presence of gallic acid, catechin, chlorogenic acid, sinapic acid, quercetin, and γ- and α-tocopherol. It has been documented that phenolics possess different pharmacological effects. Phenolics have been reported to possess anti-inflammatory activity. Quercetin reduces symptoms of rheumatoid arthritis by preventing the generation of NO, TNF-α, and PGE2 and activation of NF-kB.^[@ref25]^ Quercetin is a flavonoid with important immunosuppressive, anti-inflammatory, antioxidant, and protective effects. It holds the potential for treating rheumatoid arthritis. The decreased intensity of rheumatoid arthritis in rats administered with quercetin was linked with reduced levels of IL-17, IL-1β, MCP-1, and TNF-α.^[@ref26]^ Catechin reduced the inflammatory paw puffiness, arthritic index, and pain response in complete Freund's adjuvant arthritis in rats. It decreased generation of TNF-α, PGE2, and IL-1β and elevated cyclic adenosine monophosphate in rats.^[@ref27]^ The anti-inflammatory potential of gallic acid might be because of the inhibition of phosphodiesterase (PGE4) activity, an elevation of IL-6, and the reduction of TNF-α of neutrophils. Sinapic acid possesses anti-inflammatory effects through subduing manifestation of COX-2, iNOS, and TNF-α.^[@ref28]^ Chlorogenic acid (CA) is a polyphenol. Various studies have shown that CA exhibits different pharmacological effects like immunoprotective, anti-inflammatory, and antibacterial activities.^[@ref29]^ The findings of the experiment by Pamila and Karpagam are in agreement with our HPLC results; they reported the presence of three compounds---phytol, 9,12-octadecadienoic acid, and vitamin E---in the ethanolic extract of *A. bettzickiana* having anti-inflammatory and antiarthritic activities.^[@ref11]^

*I*n* silico* molecular docking was performed to further investigate the anti-inflammatory mechanism of phytochemicals in therapeutics of arthritis. The phytochemicals were simulated by induced fit docking to investigate their inhibitory potential for COX-1 and COX-2. Induced fit docking is a unique approach that considers the flexibility of the binding pocket during docking of the ligand and accurately simulates the ligand--receptor complexation. Herein, docking analysis highlighted γ-tocopherol as the most potent inhibitor of COX-1, which significantly inhibited the standard threshold while maintaining the conserved interactions of Ibuprofen. Interestingly, α-tocopherol also showed comparable binding affinity to γ-tocopherol, but it could not extend through the constriction point and deep into the COX-1 catalytic site. Although sinapic acid penetrated efficiently into the active site, its affinity was found to be comparable to the standard threshold. On the other hand, α-tocopherol exhibited the highest binding affinity and potent inhibitory potential for COX-2, where it blocked the restricted hydrophilic site to selectively inhibit COX-2 activity. Although catechin and quercetin follow the binding affinity of α-tocopherol, these phytochemicals revealed diverse inhibitory potentials to selectively block COX-2 catalytic activity. Therefore, these structural insights may highlight the potential anti-inflammatory lead compounds with a novel chemical scaffold to potently and selectively inhibit the cyclooxygenase activity in arthritis.

The therapeutic agent retaining the antiarthritic potential also possesses antioxidant activity, so the antioxidant activity of *A. bettzickiana* extract was also evaluated utilizing ABTS, DPPH, and ferric reducing power assay. There is equilibrium between free radicals and antioxidants. Disturbance in this equilibrium causes oxidative stress and destroys the cellular components. They cause disease conditions like inflammation. Oxidative injury is a key factor in several diseases like inflammatory disorders, arising from free radicals, which gain power by electron linking with biological macromolecules like proteins, DNA, and lipids in living cells.^[@ref30]^ Antioxidants demilitarize reactive oxygen species. Antioxidants inhibit cellular damage from free radicals by counteracting oxidation of molecules. Thus, antioxidants produce anti-inflammatory responses.^[@ref31]^ Antioxidant compounds subsisting in plants, *e.g*., flavonoids, terpenoids, phenolics, alkaloids, tannins, quinones, proanthocyanidins, stilbenes, lignins, and metabolites, have been documented to provide protection against disorders consisting of free radicals and reactive oxygen species.^[@ref32]^ The lesser the IC~50~ value, the greater the antioxidant activity in ABTS and DPPH assays; and the higher the reducing power, the higher the antioxidant activity in the FRAP assay. The current study displayed that *A. bettzickiana* ethanolic extract exhibited strong antioxidant potential in *in vitro* antioxidant models. Our findings of DPPH radical scavenging and reducing power assays were in agreement with the study of Vidhya et al.^[@cit14d]^ Phytochemical analysis of the ethanolic extract of *A. bettzickiana* showed the presence of flavonoids, polyphenolics, and alkaloids. Hence, reducing power and free radical scavenging of *A. bettzickiana* could be linked to flavonoids, polyphenolics, and alkaloids because they are familiar for their redox and antiradical effects and associated with anti-inflammatory activity of *A. bettzickiana*.^[@ref33]^

As reported in a previous study, various biologically active phytocompounds like fatty acids (linoleic acid, *n*-hexadecanoic acid), vitamins (vitamin E), triterpenoids (squalene, phytol), and sesquiterpenoids (farnesol, Ar-turmerone) in ethanolic extract of plants are accountable for their remarkable anti-inflammatory effects. The additional separation of active phytocompounds, which are responsible for antiarthritic activity, should be carried out.

Most of the research have documented that protein denaturation is a reason for rheumatoid arthritis. Auto antigen generation in different disorders could be due to protein denaturation. Protein denaturation involves modifications in hydrophobic electrostatic and disulfide linkage. In the present study, *A. bettzickiana* ethanolic extract remarkably prevented thermal protein denaturation in *in vitro* assays. Accordingly, it could be accepted due to these outcomes; protection against protein denaturation and auto antigen production of *A. bettzickiana* may probably be responsible for its antiarthritic potential.^[@ref34]^ In the current study, our findings of protein denaturation assays using fresh hen albumin and bovine serum albumin were in agreement with previously documented research work in which plant extracts and standard exhibited a dose-dependent inhibition of protein denaturation.^[@ref34],[@ref35]^

Administration of rats with CFA produces severe inflammation (reported by synovial membrane penetration, joint remodeling, and severe swelling), which carry a similarity to arthritic features of rheumatoid arthritis in humans (reported by joint pain, cartilage destruction, paw edema, and weight loss^[@ref36]^). The adjuvant administration causes puffiness and edema of paws/joints of rats, marking the development of inflammation. CFA was chosen for the current study because it is a commonly utilized animal model for studying rheumatoid arthritis, inflammation, and autoimmune diseases. The development of CFA-induced arthritis is categorized into various phases (like in humans) starting with the induction phase with no validation of synovitis later by early synovitis, followed by synovitis with joint destruction. Good antirheumatic drugs should ameliorate these phases.^[@ref37]^ In primary arthritis, prostaglandins are produced and inflammation is developed, while the secondary phase happens when autoantibodies are produced. The liberation of various inflammatory mediators like interferon and cytokines (IL-IB, TNF-α) play a crucial role in the development of pain, disorder of joint function, bone distortion, and inflammation of joints.^[@ref38]^

Paw edema is associated with cellular permeation in the inflammatory area, vascular penetrability, and rise in fluid discharge.^[@ref39]^ This parameter is easy to measure, providing a fast method for evaluating the effectiveness of antiarthritic drugs.^[@ref40]^ The decrease in paw thickness shows a decrease in the discharge of inflammatory mediators and is a sign of anti-inflammatory effect of a drug in CFA-induced arthritis.^[@ref41]^ In the disease control group, swelling continued for 28 days because of cellular invasion and constant edema. However, in treatment groups, the maximum swelling was on day 7, after which inflammation started to abate. Ethanolic extract of *A. bettzickiana* showed a striking decrease in paw diameter in comparison with disease control rats.

Our results of paw diameter for assessment of the antiarthritic potential were in agreement with the study of Mali et al., in which there was a remarkable increase in paw volume in adjuvant-injected rats in comparison to vehicle control rats, while treatment with *Phyllanthus amarus* extract reduced the paw volume, which was noticed until the 28th day of study.^[@ref42]^ In another study, it was observed that paw thickness of arthritic rats increased significantly, while considerable reduction in paw thickness was noticed in rats treated with *Berberis calliobotrys* extracts in contrast to CFA control rats at 200 mg/kg dose on the 15th day of study.^[@ref43]^

Arthritic scoring is a benchmark of puffiness of joints succeeding to introduction in a CFA-induced arthritic study. A decrease in the arthritic index differentiates the immunosuppressive property of *A. bettzickiana* from the anti-inflammatory property.^[@ref37]^*A. bettzickiana* extract significantly reduced the arthritic index and protected against morphological alterations of rheumatoid arthritis by reducing swelling and redness, along with inhibiting the growth of secondary lesions because of its antiarthritic potential.^[@ref34]^ Our findings of arthritic scoring in the CFA-induced arthritic study are synchronous with a previous study of Uttra et al.^[@ref34]^ They reported that CFA injection showed arthritic lesions in arthritic rats in contrast to vehicle control rats, while administration of *Ribes orientale* reduced these arthritic signs. On the 28th day of treatment, all animals administered with *R. orientale* extract, fractions, and piroxicam significantly reduced the arthritic score. They observed that the highest decrease in arthritic score was achieved with aqueous ethanolic extract.^[@ref34]^

Rheumatoid arthritis is linked with loss of lean body mass and weight. This is acknowledged as rheumatoid cachexia.^[@ref44]^ Past research proposed that decrease in body weight is associated with inflammation due to prevention of absorption of nutriments by guts, and administration with anti-inflammatory medications establishes the absorption procedure. *A. bettzickiana* produced a significant rise in body weight. The clearcut restoring of body weight in extract-treated rats may be associated with better absorption of nutriments from the gut and inhibition of pain produced by the rigorousness of arthritis.^[@ref45]^ The current study demonstrated that ABEE constantly averted weight loss by repressing the expression of TNF-α. This may be attributed to amelioration in the condition of animals by reducing inflammation associated with arthritis.^[@ref46]−[@ref48]^ In previous studies, it has been reported that there is remarkable reduction in the body weight of adjuvant-injected animals in contrast to vehicle control rats. *Justicia gendarussa* and *Withani somnifera* significantly ameliorated the body weight as compared to disease control rats in both collagen- and CFA-induced arthritic animals.^[@ref49]^ It has been described in another previous study that rats in the disease control group lose body weight in contrast to rats administered with *Mesua ferrea*.^[@ref45]^

It has been stated that CFA injection evokes T cells that trigger monocytes and macrophages, thus producing proinflammatory cytokines like IL-1β, TNFα, and IL-6, which accelerate bone erosion, joint damage, and cell death in the joints of arthritic rats.^[@ref36]^ Overproduction of the tumor necrosis factor α enhances the expressions of IL-6, PGE2, and IL-1β,^[@ref50]^ producing degrading enzymes, stimulates osteoclast differentiation, and hence promotes the development of arthritic erosions,^[@ref51]^ transfer of leukocytes, and vasodilation in the area of edema. IL-6 encourages autoantibody generation and bone resorption.^[@ref12]^ Hence, any substance that inhibits the actions of TNF-α, IL-6, and IL-1β carries great importance in the treatment of RA.^[@cit51b]^ Moreover, proinflammatory cytokines trigger chemokines, hence monocytes and neutrophils are released near the inflamed area.^[@cit26b]^ Bone destruction could be avoided by inhibiting TNF-α, which expresses matrix metalloproteinase, specially MMP13 and MMP1, which cause bone injury.^[@ref52]^ The current study showed a pronounced reduction in the expressions of IL-6, TNF-α, and IL-1β in comparison to disease control rats.

In the current study, the increased concentrations of TNF-α and IL-6 measured by ELISA kits in the serum of disease control rats were significantly reduced by treatment with ABEE and diclofenac sodium in contrast to the disease control group. Our findings are in agreement with a prior study in which TNF-α levels were estimated by the ELISA kit in CFA-induced arthritis. It was reported that CFA injection resulted in elevated serum TNF-α levels; however, these effects were altered by *Cinamomum cassia* hydroalcoholic extract administration in a dose-dependent way in contrast to disease control rats. However, TNF-α concentration in disease control rats was twofold as compared to rats treated with indomethacin and *C. cassia* hydroalcoholic extract.^[@ref53]^ Our results of consequences of ABEE on serum TNF-α, PGE2, and IL-1β levels were in agreement with a prior research work in which the level of these inflammatory mediators in the serum of CFA-injected rats was remarkably elevated. Compared with CFA-injected rats, ethyl acetate and ethyl ether extract of *Polygonum orientale* significantly reduced the concentrations of TNF-α, IL-1β, and PGE2 in serum. Dexamethasone acetate significantly reduced the TNF-α, IL-1β, and PGE2 levels in serum.^[@ref54]^

IL-1β stimulates matrix metalloproteinase production and osteoclast activation, leading to bone injury.^[@cit14b]^ IL-1β stimulates autoantibody generation and bone resorption.^[@ref12]^ NF-kB is associated with osteoclast differentiation and stimulation, which result in bone loss and synovial apoptosis. NF-kB modulates the immune system *via* transcription of inflammatory biomarkers like IL-6, IL-1β, TNF-α, and nitric oxide synthase. NF-kB is inhibited by I-kB. NF-kB stimulation exacerbates arthritis.^[@ref55]^ The disease control group exhibited reduced expression of I-kB and elevated expression of NF-kB. However, the opposite was noticed in rats treated with ABEE. So NF-kB blockers possess therapeutic efficacy and could be used for treating RA.^[@ref56]^ PGE2 formed from arachidonic acid is of particular concern in the synovial membrane. Elevated concentrations of PGE2 are linked with inflammation, erythema, pain, vasodilation, fluid discharge, and bone loss.^[@ref36],[@cit51a]^ Inflammatory cytokines evoke expression of COX-2 and indirectly increase PGE2 concentration in the synovial cell.^[@ref50]^ ABEE reduced synovitis and angiogenesis through the reduced expression of COX-2 and PGE2.

IL-10 and IL-4 are immunoregulatory cytokines; IL-4 blocks Th1 production and supports formation of the Th2 cell.^[@ref56]^ IL-10 prevents Th1-cell-generated cytokines (IL-1β, IFN-γ, TNF-α) and blocks the expression of IL-18 mRNA. It also reduces the actions of antigen-presenting cells and guards the integrity of joints.^[@ref46]^ IL-10 and 1L-4 stop inflammation, bone loss, and cartilage destruction in RA as compared to inflammatory cytokines. The findings of the present study exhibited increased levels of IL-10 and IL-4 in treated groups as compared to disease control rats. Results of the present study showed that ABEE notably reduced mRNA expressions of IL-6, TNF-α, NF-kB, and IL-1β and also reduced the levels of inflammatory enzymes (COX-2); however, considerably increased mRNA expressions of I-kB, IL-10, and IL-4 were observed. Thus, in addition to the reduction of inflammatory cytokines and elevation of immunoregulatory cytokines, arachidonic acid breakdown could be another mechanism responsible for the antiarthritic activity of ABEE. These findings firmly revealed the antiarthritic activity of *A. bettzickiana* and therefore indicate *A. bettzickiana* as optimal therapy for treating RA.

Our results on the mRNA expression level of proinflammatory and anti-inflammatory cytokines corroborate with those of Hassan et al.'s^[@ref48]^ study, where they observed remarkably decreased expression levels of COX-2, IL-1β, and NF-kB with significant inhibition of TNF-α by aqueous ethanolic extract, aqueous fraction, and standard drug piroxicam. Furthermore, nonsignificant inhibition of NF-kB and significant suppression of expression levels of IL-1β and COX-2 were observed in butanol-treated rats in contrast to disease control rats. Moreover, significantly increased levels of IL-10 and IL-4 have been noticed in rats administered with hydroethanolic extract, butanol, and aqueous fractions and piroxicam as compared to disease control.^[@ref48]^

In an earlier study, significant reduction in the expressions of IL-4, IL-10, and 1-kB and a significant upsurge in the expressions of TNF-α, IL-1β, COX-2, and NF-kB were observed in disease control. However, treatment with methanolic and aqueous extracts of *Moringa rivae* leaf extracts and piroxicam increased the expression levels of IL-4, IL-10, and 1-kB and decreased the expression levels of TNF-α, IL-1β, COX-2, and NF-kB in contrast to the arthritic control.^[@ref5]^

The CFA model is also utilized to analyze biochemical and hematological differences. The decrease in Hb and RBC levels in CFA rats led to anemia, which develops from bone marrow failure, reduced erythropoietin, and finally erythrocyte damage.^[@cit25b]^ These processes are affected by IL-1β. *A. bettzickiana* and diclofenac sodium considerably increased Hb and RBC values, *i.e*., inhibited the onset of anemia due to decreasing IL-1β values in contrast to disease control groups. In addition to the elevation in platelets and WBCs, results from activation of the immune system attacking pathogens and release of TNF-α and IL-1β were noticed in disease control rats. The decrease in treated rats exhibited immunomodulatory action of *A. bettzickiana* due to the decrease in TNF-α and IL-1β values.

Similarly, the disease control group exhibited an increase in the ESR count, which shows an enhanced level of inflammatory proteins in the blood due to increased IL-6 concentration. However, ABEE and the standard drug diclofenac sodium considerably decreased the level of IL-6, which in turn decreased the formation of inflammatory cytokines and thus the ESR. Elevated quantity of the rheumatoid factor was seen in the serum of the disease control group, although a considerable decrease was noticed in rats treated with diclofenac sodium and *A. bettzickiana*, which exhibited the protective action of the plant in treating rheumatoid arthritis.^[@ref57]^ Earlier research have documented that cytokines like IL-6, TNF-α, and IL-1β regulate the formation of C reactive protein (CRP) from the liver. *A. bettzickiana* ethanolic extract alleviated the expressions of IL-6, IL-1β, and TNF-α, which in turn reduced the serum CRP concentration in disease control rats and decreased the inflammation associated with rheumatoid arthritis.^[@ref58]^ Increased serum AST and ALT levels are associated with enhanced bradykinin concentrations in inflammation and show hepatotoxicity.^[@ref59]^ However, the ALP function is associated with annihilation of the bone and is an assessment of lysosomal integrity. In the current research, increased ALP values in blood were observed in disease control animals. *A. bettzickiana* ethanolic extract and the standard drug (diclofenac sodium) remarkably decreased ALP values, which may suggest the increased lysosomal stability and decreased bone weakening, as supported by radiographic examination in the current study.^[@ref60]^ Similarly, creatinine and urea levels in the blood were elevated in disease control rats because of reduction in kidney function.^[@ref61]^ However, all treatment groups showed reduced serum creatinine and urea. Thus, the outcomes of biochemical and hematological evaluation attest to the protective effect of *A. bettzickiana*, hence suggesting its powerful antiarthritic activity.

Our outcomes on hematological variables in the CFA-induced arthritic model are synchronous with a prior study of Jalalpure et al.^[@ref45]^ It indicated that adjuvant-induced hematological parameters like elevation in the WBC count and ESR and reduction in RBC and HB were also considerably changed by *M. ferrea* administration at 300 mg/kg and 500 mg/kg oral dose, supporting our current results.^[@ref45]^ The current results are in accordance with those of Uttra et al.,^[@ref34]^ where a decrease in Hb and RBCs and an increase in platelets were observed, and ESR and WBCS counts were reported in CFA-injected arthritic animals. Furthermore, increased ALP, ALT, AST, RF, and CRP levels were noted in disease control animals, while treatment with *R. orientale* extract, its aqueous and *n*-butanol fractions, and piroxicam decreased these levels in serum. These results showed that extract, fractions, and the standard drug did not show liver and kidney damage at tested doses. Moreover, the noticeably increased creatinine and urea concentrations in the CFA-injected group decreased when using the plant extract, its fractions, and piroxicam.^[@ref34]^

Rheumatoid arthritis attacks the synovium, producing joint swelling, which can be observed by histopathological analysis.^[@ref36]^ NF-kB and cytokines like IL-6, PGE2, TNF-α, and IL-1β are linked with the development of symptoms of rheumatoid arthritis, specifically attack of the synovial membrane by inflammatory cells, joint and bone damage, synovial hyperplasia, and pannus development.^[@ref12],[@ref56]^ Antiarthritic results were also supported by histological studies. From the histological outcomes, it was obvious that inflammation was controlled by administration with *A. bettzickiana* (250, 500, 1000 mg/kg). The histopathological slides also elucidated that *A. bettzickiana* reduced lymphocyte and neutrophil infiltration and vascularity with less swelling and synovial membrane thickness as compared to the disease control group. Histopathological outcomes have shown the antiarthritic effect of the plant. In a previous study, it was reported that disease control rats showed damaged joint cartilage, macrophage infiltration, and synovial hyperplasia. Rats treated with *Cinnamomum cassia* hydroalcoholic extract at 200 mg/kg dose exhibited a significant decrease in arthritic severity, cartilage damage, and infiltration of cells, in contrast to the results in disease control rats. The synovial lining was also intact. These results supported our recent findings.^[@ref53]^

To validate disease reoccurrence and determine the disease state, radiographic examination is crucial.^[@ref62]^ Bone loss in disease control animals caused less bone conformation with enhanced bone resorption. Therefore, histopathological and radiographic evaluation of CFA-injected animals specifies that ethanolic extract of *A. bettzickiana* and the standard drug diclofenac sodium suppress rheumatoid arthritis-linked joint/bone damage and histopathological impairment of tissue sections of the ankle joint, which may be linked with a decreased expression of previously mentioned cytokines by *A. bettzickiana*. Our findings of radiographic analysis in the CFA-induced arthritis study are synchronous with a prior study of Uttra et al.^[@ref34]^ The study indicated that CFA-injected control animals showed extensive bone erosion, joint deformity, bone resorption, soft tissue swelling, no joint spaces, and remarkably dense connective tissue in contrast to vehicle control animals. Similarly, these radiographic alterations were ameliorated in all animals treated with *R. orientale* aqueous ethanolic extract and its aqueous and *n*-butanol fractions.^[@ref34]^

It is proposed that CAT and SOD levels were decreased, while MDA and NO levels were increased in arthritis, as shown in this study. However, diclofenac sodium (10 mg/kg) and 500 and 1000 mg/kg dose of ABEE restored (*p* \< 0.001) the values of SOD, CAT, MDA, and NO in arthritic rats in contrast to disease control rats. A previous study supported our findings that antioxidants like GPx, CAT, SOD, and GSH were reported to be considerably reduced in CFA-induced arthritis rats in contrast to control animals. These levels were restored to normal levels in animals administered with *Semecarpus anacardium* nut extract.^[@ref63]^ Oxidative stress negatively affects gene transcription.^[@ref52]^ Adjuvants increase the concentration of inflammatory cytokines and reactive oxygen species, which elicit immune cells to liberate enzymes and cytokines to aggravate RA.^[@cit25b]^ Thus, it could be postulated that alleviation of oxidative stress by ABEE could be one of the principal mechanisms for suppressing gene expression of cytokines involved in inflammation in RA.

Therefore, inhibition of radical scavenging effect, protein denaturation inhibition, results of adjuvant-induced arthritis model like reduction in paw thickness, scoring, amelioration in hematological and biochemical variables, decreased body weight, histopathological and radiographic examination support anti-inflammatory and antiarthritic potential of *A. bettzickiana* that might be due to its polyphenolics and vitamin E constituents.

4. Conclusions {#sec4}
==============

A strong interaction between HPLC compounds and cyclooxygenase enzymes occurred in the docking study, showing the potential of plant constituents to have antiarthritic effect. The CFA-induced arthritic rat model had reduced the arthritic index, prevented weight loss, and stopped abnormal alteration in biochemical and hematological variables, bone and cartilage destruction, pannus formation, and anemia on treatment with ABEE. Gene expressions of NF-kB, COX-2, IL-6, TNF-α, and IL-1β decreased, whereas IL-10, I-kB, and IL-4 increased in the treatment groups as compared to the disease control. So the plant slowed down the progress of rheumatoid arthritis in a concentration-dependent manner. The best dose of ABEE, which exhibited the maximum antiarthritic effect, was 1000 mg/kg. The antiarthritic effect of *A. bettzickiana* proposed the need for separation of specific compounds accountable for the antiarthritic activity. These should be assessed for their signaling pathways for treating rheumatoid arthritis.

5. Materials and Methods {#sec5}
========================

5.1. Plant Collection {#sec5.1}
---------------------

Aerial parts of the plant were collected from Punjab in March 2019. Plant identification and authentication were done by Dr. Mansoor, Department of Botany, University of Agriculture (UAF), Faisalabad. Voucher no. 520-1-13 was issued for the crude sample to the UAF herbarium.

5.2. Preparation of Extract {#sec5.2}
---------------------------

*A. bettzickiana* was washed and dried under shade until complete drying and then ground to a fine powder. The microwave extraction method was used. Briefly, the extraction procedure is as follows. The microwave was set at 9000 W. This method consisted of three cycles. In the first cycle, 750 mL of ethanol was added to 100 g of powder in a beaker having 1000 mL capacity. The beaker was placed in a microwave oven, run for 2 min and then stopped, and the door was opened for 30 s. This process was repeated five times. The same process was repeated for the other two cycles, and 500 mL of ethanol was added each time in these two cycles. The extract was filtered by Whatman filter paper. Extracts from each cycle were pooled up, and the excess solvent was removed by a rotary evaporator at 40 °C. The semisolid extract was stored in amber-colored bottles for further analysis.^[@ref64]^

5.3. Animal Husbandry {#sec5.3}
---------------------

Healthy young adult Wistar rats of both sexes were purchased from the University of Agriculture. They were housed in the animal house of the Govt. College University Faisalabad (GCUF) for 5 days before the start of the experimental work to acclimatize them with the new environment. The animal house was maintained according to internal standards having temperature 22 ± 3 °C, relative humidity ranging from 30 to 70%, and a 12 h light--dark cycle. Normal laboratory diet for rodents was used for feeding, with unlimited drinking water supply.

### 5.3.1. Ethical Approval {#sec5.3.1}

Experimental work on animals was performed after getting approval from the Institutional Review Board of the Govt. College University Faisalabad vide reference no. GCUF/ERC/2143. Guidelines regarding the safety and experimental animal handling by the National Institute of Health (NIH) guidelines were followed.

5.4. Plant Characterization {#sec5.4}
---------------------------

### 5.4.1. Physicochemical Analysis {#sec5.4.1}

Physicochemical properties of the extract were evaluated to determine the moisture content, water, acid-insoluble ash, total ash, alcohol, water-soluble extractives, and sulfated ash contents.^[@ref20]^

#### 5.4.1.1. Moisture Contents {#sec5.4.1.1}

Two grams of powdered plant was weighed in a tarred China dish. The plant material in a China dish was dried at 105 °C for 80 min by putting the China dish in an oven. The powdered plant was then cooled and weighed. The weight of the dried powdered plant was determined by deducting its empty weight from the combined weight of the powdered plant and the China dish. Moisture contents were assessed using the following equation

#### 5.4.1.2. Total Ash {#sec5.4.1.2}

The powdered plant was taken and weighed. The China dish with the plant material was incinerated at 675 ± 25 °C in a furnace. The China dish with carbon-free ash was put in a desiccator for cooling. Ash contents were then assessed, and the percentage of total ash was calculated.

#### 5.4.1.3. Sulfated Ash {#sec5.4.1.3}

The powdered plant (2 g) was taken in a China dish and mixed with sulfuric acid to prepare a paste. It was then ignited until white fumes stopped appearing from the plant material. The China dish was then placed in a desiccator for cooling purposes. Ash contents were then estimated. The percentage of sulfated ash was calculated.

#### 5.4.1.4. Alcohol-Soluble Extractives {#sec5.4.1.4}

Ethanol (100 mL) was added to a powdered plant (5 g) in a flask. The powdered plant was macerated for 24 h with continuous shaking. It was then filtered. Twenty-five milliliters of filtrate was dried by evaporation. The dried residue was obtained by keeping in an oven at 105 °C. It was then weighed. The percentage of alcohol-soluble extractives in relation to the powdered substance was calculated.

#### 5.4.1.5. Water-Soluble Extractives {#sec5.4.1.5}

Distilled water (100 mL) was added to the powdered plant (5 g) in a flask. The powdered plant was macerated for 24 h with continuous shaking. It was then filtered. Twenty-five milliliters of filtrate was dried by evaporation. The dried residue was obtained by keeping in an oven at 105 °C. It was then weighed. The percentage of water-soluble extractives in relation to the powdered substance was calculated.

#### 5.4.1.6. Acid-Insoluble Ash {#sec5.4.1.6}

The total ash obtained from the powdered substance was boiled for 5 min in HCl (25 mL). The boiled matter was filtered. The insoluble material piled up as residue on a filter paper, while the soluble material accumulated as filtrate. The residue was washed with distilled water to remove all of the soluble matter. The dried filter paper was burnt in a China dish until the ash became carbon-free. Ash contents were cooled and weighed. The percentage of acid-insoluble ash was estimated in relation to the total ash utilized.

#### 5.4.1.7. Water-Insoluble Ash {#sec5.4.1.7}

The total ash obtained from the powdered substance (2 g) was boiled for 5 min in distilled water (25 mL). The boiled matter was filtered. The insoluble material piled up as residue on a filter paper, while the soluble material accumulated as filtrate. The residue was washed with distilled water to remove all of the soluble matter. The dried filter paper was burnt in a China dish until the ash became carbon-free. Ash contents were cooled and weighed. The percentage of water-insoluble ash was estimated in relation to the total ash utilized.

### 5.4.2. Phytochemical Analysis {#sec5.4.2}

Phytochemical analysis was carried out to evaluate the phytochemicals of the plant extract. The plant extract was evaluated for estimating secondary metabolites like total alkaloids, total polyphenolics, and total flavonoids.

#### 5.4.2.1. Estimation of Total Polyphenolics {#sec5.4.2.1}

The extract and standard each (0.2 mL) were put in test tubes. The same quantity of Folin--Ciocalteu's phenol reagent was mixed with them. After 4 min, 1 mL of Na~2~CO~3~ solution was added. These solutions were kept for 2 h at room temperature before taking the absorbance at 760 nm. The blank contained all reagents, except the analyte. Total polyphenolics were determined by the linear regression equation as milligram of gallic acid equivalents.

Total polyphenolics were estimated by the following equation

The test was done in triplicates. Gallic acid was utilized for drawing the standard curve.^[@ref65]^

#### 5.4.2.2. Estimation of Total Flavonoids {#sec5.4.2.2}

The sample and standard each (0.2 mL) were separately mixed with 0.1 mL of aluminum nitrate solution and potassium acetate and 4.6 mL of distilled water in test tubes. These solutions were incubated for 45 min before taking the absorbance at 415 nm. The blank contained all reagents excluding the analyte. Total flavonoids were estimated using the regression equation as milligram of quercetin equivalents. Total flavonoids were estimated using the following equation^[@ref66]^

The test was done in triplicate. Quercetin (QTN) was utilized for drawing the standard curve.

#### 5.4.2.3. Estimation of Total Alkaloids {#sec5.4.2.3}

Piperine was used for drawing the standard curve. A solution of the sample and standard (100 μL) was mixed with 2 μL of sulfuric acid and gallic acid and 5% methanolic solution (100 μL). These solutions were heated in a water bath for a time period of 10 min before taking the absorbance at 660 nm. The blank test tube was composed of methanol in place of the sample. Total alkaloids were estimated from the regression equation as milligram of piperine equivalents.^[@ref20]^ Total alkaloids were assessed using the following equation

### 5.4.3. High-Performance Liquid Chromatographic (HPLC) Analysis {#sec5.4.3}

This method was used to segregate phenolic acids and vitamin E from samples with different matrixes in one run. The sample was run through a Chromera HPLC system (PerkinElmer) equipped with a Flexar binary LC pump and controlled by v.42.6410 software. A C18 phase column of width 250 × 4.6 mm^2^, film thickness 5 μm, particle size 5 m, with an oven at 30 °C and a UV/V LC detector (Shelton, CT) was utilized for analysis. The mobile phase for phenolics consisted of solvent A (methanol/acetonitrite, 30:70) and solvent B (0.5% glacial acetic acid with double-distilled water), while for vitamin E it consisted of only one solvent (acetonitrile/methanol/methylene chloride, 44:50:6).^[@ref67]^ The binary gradient solvent system HPLC method could separate flavonoids (1--4) and phenolic acids (8--9) within 30 min. The flow rate of the mobile phase was 0.8 mL/min. The separation factors of separated compounds were more than 1.0, and resolutions were more than 1.5. The peaks were recorded at 275 nm by a UV--visible detector. The analytes were recognized by matching spiking samples and retention times with standards, and quantification was done with an external standard quantification method. HPLC separation efficiency was evaluated by resolution and separation factors.^[@ref68]^

5.5. *In Silico* Molecular Docking {#sec5.5}
----------------------------------

The antiarthritic activity was further investigated in computational modeling of phytochemicals for their anti-inflammatory potential by the function of the induced fit docking protocol in Molecular Operating Environment 2015.10. The three-dimensional (3D) X-ray crystallized structures of cyclooxygenase 1 (Protein Data Bank (PDB) ID: 1HT8) and cyclooxygenase 2 (PDB ID: 3LN1) were retrieved from the RSCB Protein Data Bank (<http://www.rscb.org>). The 3D conformers of ibuprofen (CID: 3672), α-tocopherol (CID: 1742129), γ-tocopherol (CID: 92729), catechin (CID: 9064), quercetin (CID: 5280343), sinapic acid (CID: 637775), chlorogenic acid (CID: 1794427), and gallic acid (CID: 370) were fetched from the PubChem database. The molecules were prepared in structure preparation application of MOE. The macromolecules were inspected and corrected for structural issues, such as H-count, termini capping, missing residues, and alternates. The protonation state was optimized by Protonate3D application, and tether restrains were added by Amber10:EHT force field minimization. The extraneous cofactor, ligands, and water molecules were removed. The binding pocket was defined by the SITE Finder application and specified in the proximity of the cocrystallized inhibitor. The ligands were docked and ranked by the Triangle Matcher placement method and the London dG scoring function, respectively. These docked poses were further refined by the Induced Fit method and scored with the GBVI/WSA dG scoring function. The cocrystallized ligand was redocked per cognate redocking to validate the docking protocol. The pose with the lowest binding energy was modeled for ligand--protein interactions in Discovery Studio Visualizer v17.2.

5.6. Antioxidant Activity {#sec5.6}
-------------------------

Antioxidant activity of the plant was calculated by performing the following assays.

### 5.6.1. Ferric Reducing Antioxidant Power (FRAP) Assay {#sec5.6.1}

The working solution was made by mixing acetate buffer 300 mmol/L of pH 3.6, 10 mmol/L tripyridyl triazine (TPTZ) in HCl (40 mmol/L) and FeCl~3~ (20 mmol/L) in a 10:1:1 ratio, respectively. The reaction mixture (200 μL) was prepared by mixing 50 μL of plant extract. The sample and 150 μL of FRAP were added in the wells of a 96-well plate. The well plate was placed on shelf for 8 min before noting the absorbance at 600 nm to calculate the reducing power of antioxidant ferric to the ferrous standard curve was made utilizing ferrous sulfate at six concentrations by twofold serial dilutions (250--7.81 μg/mL). Results were presented as nmol Fe^2+^ equivalent/mg dry extract.^[@ref69]^

### 5.6.2. 2,2-Diphenyl-1-picryl Hydrazyl (DPPH) Assay {#sec5.6.2}

The DPPH assay was carried out in a 96-well microplate. Briefly, 100 μL of the sample at various concentrations in methanol was added to 0.01% methanolic DPPH solution (100 μL). The plate was then incubated at ambient temperature for half an hour before noticing the absorbance at 540 nm. Quercetin was used as the reference drug at various concentrations (5--25 μg/mL).^[@ref69]^ The scavenging potential was assessed using the following equationwhere AC is the absorbance of the control (DPPH and methanol without the sample) and AS is the absorbance of the test sample (DPPH and the sample); the sample is the standard or the extract.

For assessing the antiradical potency, concentration of the substrate causing 50% reduction in DPPH color (IC~50~) was calculated.

### 5.6.3. 2,2-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) Assay {#sec5.6.3}

The ABTS radical cation solution was made by mixing 4.9 mmol/L potassium persulfate solution and 14 mmol/L ABTS solution in equal amounts. The solution was allowed to react at room temperature in the dark for 16--20 h before use. Then, 1 mL of this solution was diluted with deionized water (40 mL) to give the working ABTS solution with absorbance 0.70 ± 0.02 at 734 nm. Next, 20 μL of six different concentrations of the sample (10 mg/mL) was mixed with the ABTS working solution (180 μL). Absorbance of test samples was noted after 6 min at 734 nm. Ascorbic acid was the reference drug used.

Results are shown in the form of IC~50~ and compared to ascorbic acid (*n* = 3). The IC~50~ value was calculated by the regression equation made from the dose-response curves of the standard and the sample.^[@ref69]^

5.7. Assessment of the Antiarthritic Potential {#sec5.7}
----------------------------------------------

### 5.7.1. *In Vitro* Assays {#sec5.7.1}

#### 5.7.1.1. Egg Albumin Denaturation Inhibition {#sec5.7.1.1}

The tested mixture was composed of fresh hen's egg albumin, phosphate-buffered saline 0.2 mL, 2.8 mL, respectively, and different concentrations of *A. bettzickiana* ethanolic extract (ABEE) and reference drug (2 mL) respectively. The control contains doubled-distilled water. These solutions were consecutively incubated at 37 ± 2 °C for 15 min and heated for 5 min at 70 °C before noting the absorbance at 660 nm.^[@cit25b]^ The following formula was used to determine the percentage inhibition

#### 5.7.1.2. Inhibition of Protein Denaturation Using Bovine Serum Albumin {#sec5.7.1.2}

Different concentrations (50--6400 μg/mL) of ABEE and the reference drug were made. The test control solution consisted of bovine serum albumin and distilled water (0.45 and 0.05 mL, respectively). The tested solution was comprised of BSA and test solution 0.45 and 0.05 mL, respectively. The product control solution consisted of the test solution and distilled water (0.05 and 0.45 mL, respectively).

The reference solution contained BSA and aspirin (0.45 and 0.05 mL, respectively). These solutions were then incubated at 37 °C for 20 min and warmed up for 3 min at 57 °C. Phosphate buffer (2.5 mL) was mixed with these solutions before taking the absorbance using a UV--visible spectrophotometer.^[@cit25b]^ Percentage inhibition was measured using the following equation

### 5.7.2. *In Vivo* Assessment of the Antiarthritic Potential of ABEE against Complete Freund's Adjuvant (CFA)-Induced Arthritis {#sec5.7.2}

#### 5.7.2.1. Disease Induction {#sec5.7.2.1}

Rheumatoid arthritis was induced by subplantar injection of CFA (0.1 mL) to the left foot pad of rats except for vehicle control animals.^[@ref5]^

#### 5.7.2.2. Experimental Design {#sec5.7.2.2}

Rats were classified into six groups (*n* = 5). The first group was vehicle control, which was administered 3 mL/kg of distilled water. Animals in the second group (disease control) received 3 mL/kg of distilled water, while those in the third group received the reference drug diclofenac sodium; the fourth, fifth, and sixth groups received extract at doses of 250, 500, and 1000 mg/kg, respectively. The test substance was administered 30 min before giving the adjuvant injection from day 0 and continued for 28 days.^[@ref34]^

#### 5.7.2.3. Arthritis Evaluation by Physical Parameters {#sec5.7.2.3}

Body weight of rats was determined on days 0, 7, 14, 21, and 28. Paw swelling was measured up to 28 days by a digital Vernier caliper on days 0, 7, 14, 21, and 28 after CFA injection. The following equation was used to determine the percentage inhibition^[@ref70]^Here, Vc is the paw edema of the control and Vt is the paw edema of the treated animals.

#### 5.7.2.4. Arthritic Index {#sec5.7.2.4}

The arthritic scoring technique was used to assess the rigorousness of rheumatoid arthritis. Morphological features of rheumatoid arthritis, such as edema and erythema, were noted. Scoring was done on days 0, 3, 7, 14, 21, and 28 after adjuvant administration using visual criteria. Both contralateral and ipsilateral paws were observed for erythema and edema. Score 0 indicates the usual paw. Scores 1--4 indicate participation of 1 digit to complete digits per paw, thus showing minimal, mild, moderate, and acute redness and swelling, respectively. Score 5 indicates involvement of the other paw.^[@ref70]^

#### 5.7.2.5. Arthritis Evaluation by Hematological and Biochemical Parameters {#sec5.7.2.5}

Blood samples were accumulated *via* cardiac puncture under chloroform anesthesia to analyze hematological parameters (red blood cells, hemoglobin, white blood cells, and erythrocyte sedimentation rate and platelet count) and biochemical variables (alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, creatinine, rheumatoid factor, C-reactive protein (CRP), and urea). Next, animals were sacrificed by a painless procedure by cervical dislocation under anesthesia.

#### 5.7.2.6. Histopathological Evaluation of Joints {#sec5.7.2.6}

Ankle joints were detached and secured in formalin (10%). Joints were decalcified by putting in 10% ethylenediaminetetraacetic acid (EDTA) for a period of 30 days. Joints were implanted in paraffin, and the (5 μm) joint segment was slashed and stained. Histopathological modifications in ankle joints like bone erosion, swelling, and pannus development were observed by a photomicroscope.^[@ref34]^

#### 5.7.2.7. Radiographic Evaluation of Joints {#sec5.7.2.7}

Legs of slaughtered animals were transected and collected for radiographic assessment by the computerized radiographic technique.^[@cit25b]^

### 5.7.3. Determination of the mRNA Expression Level by Real-Time Quantitative Polymerase Chain Reaction (RT-PCR) {#sec5.7.3}

NF-kB, TNF-α, IL-1β, COX-2, IL-4, IL-6, I-kB, and IL-10 levels were estimated in blood by real-time quantitative PCR. Blood collected from rats was taken in EDTA tubes, and RNA was extracted from blood by the Trizol method. Reverse transcription was carried out according to the manufacturer's protocol (Thermo scientific cDNA synthesis kit; K1622). Briefly, 1 μg of RNA was taken and then 1 μL of oligo (dt)^[@ref18]^ primer and nuclease-free water were added to make the total volume of 12 μL. The mixture was incubated at 65 °C for 5 min. The vial was chilled down by placing in ice. Then, 4 μL of the 5× reaction buffer, 1 μL of RiboLock RNase inhibitor, 2 μL of 10 mM dNTP mix, and 1 μL of RevertAid M-MuLV RT were added to it to make the final volume of 20 μL. The mixture was incubated for 60 min at 42 °C. The reaction was terminated by incubating at 70 °C for 5 min. RT-PCR was used for amplification and quantification of the sample *via* the Bio-Rad system. The kit procedure of Maxima sybr green/ROX qPCR master mix (2×), K0221, was adopted. Briefly, 2 μL of cDNA was mixed with 10 μL of Sybr mix, 1 μL each of forward and reverse gene-specific primers, and 6 μL of nuclease-free water. The mixture was poured into the wells of a microplate. The plate was put in a thermal cycler. The microplate was set at 94 °C for 5 min with 35 cycles of initial denaturation at 94 °C for 35 s, annealing at 58 °C for 35 s, and finally extension at 72 °C for 45 s. Housekeeping and different inflammatory biomarkers were designed utilizing a gene bank, primer 3, and primer quest, which are depicted in [Table S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf).^[@ref34]^ Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was utilized as the housekeeping gene.

### 5.7.4. Enzyme-Linked Immunosorbent Assay (ELISA) {#sec5.7.4}

ELISA was performed to measure the serum concentrations of TNF-α and IL-6 utilizing kit protocols (Elabscience, catalog numbers E-EL-R0019 and E-EL-R0015).^[@cit51a]^

### 5.7.5. Determination of Oxidative Stress Biomarkers {#sec5.7.5}

The serum level of NO was estimated utilizing the NO ELISA kit (Elabscience, catalog number E-BC-K036). Absorbance was noted by a microplate ELISA reader (BI, 800TS-UV). The level of oxidative stress and antioxidant enzymes was determined by estimating the serum concentrations of SOD (Elabscience, catalog number E-BC-K020), CAT (Elabscience, catalog number E-BC-K106), and MDA (Elabscience, catalog number E-EL-0060) on the 28th day of study.

5.8. Statistical Analysis {#sec5.8}
-------------------------

The results were presented as mean ± SEM and statistically analyzed by one- and two-way ANOVA followed by Bonferroni's post-test using graph pad prism version 5. Two-way ANOVA was applied to analyze, *in vitro*, the antiarthritic activity, paw diameter, scoring, body weight, and hematological and biochemical variables of CFA-induced arthritis. However, one-way ANOVA was tried to analyze the mRNA gene expression of inflammatory biomarkers, inflammatory mediators measured by ELISA, and oxidative stress biomarkers. *p* \< 0.05 was set as a statically significant value.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c01670](https://pubs.acs.org/doi/10.1021/acsomega.0c01670?goto=supporting-info).Docking figures, docking table, body weight of rats on different days of the study, biomarkers and primers for the RT-PCR experiment ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01670/suppl_file/ao0c01670_si_001.pdf))
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